Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP
FIGURE 5. Therapeutic Focus of Clinical Trials Based on a Number of Studies, 2005/6 - 2009/10
4%
4%
7%
4%
6%
3%
3%
11%
6%
24%
14%
9%
15%
“Other” includes anesthesiology, autoimmune, critical care, dental, dermatology, emergency medicine, hematology, musculo-skeletal,
neonatology, obstetrics and gynecology, ophthalmology, surgery, and transplant.
The distribution in terms of disease specialty and funding of the more than 200 pediatric trials included
in this report is somewhat different to the overall pattern, as can be seen in Figure 7. Trials on diseases
and disorders of the CNS, particularly epilepsy, Fetal Alcohol Spectrum Disorders, and Attention Deficit
Hyperactivity Disorder, are the most common, followed by infectious diseases/ infection (mainly vaccine
trials) 16 . The most common pulmonary trials targeted cystic fibrosis, respiratory syncytial virus, and
asthma.
23%
17%
23%
18%
9%
Cancer
CV/Cardiology
CNS
ID/Infection
Gastrointestinal
Genitourinary
Metabolic/Endocrine
Pulmonary
Other
FIGURE 6. Therapeutic Focus of Clinical Trials Based on Amount of Funding, 2005/06 - 2009/10
Cancer
CV/Cardiology
CNS
ID/Infection
Gastrointestinal
Genitourinary
Metabolic/Endocrine
Pulmonary
Other
16 Note that pediatric cancer trials do not come with individual trial funding and funding related to disease underestimates the
amount of activity in this area. Using infrastructure funds from the international Children’s Oncology Group (COG), virtually every
child is entered into cancer clinical trials that are seamlessly integrated into their health care.
25